Figure 2.

Mean (SD) and change from baseline to 6‐month post‐treatment‐initiation scores for BASDAI‐related endpoints in HLA‐B27–positive (A) and HLA‐B27–negative (B) patients with axial PsA. Scores ≥4 indicate suboptimal control of disease. ^*BASDAI Question 2 (How would you describe the overall level of AS neck, back or hip pain you have had?). ^†Excludes BASDAI Question 3 (How would you describe the overall level of pain/swelling in joints other than neck, back, hips you have had?). BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; HLA, human leukocyte antigen; PsA, psoriatic arthritis; SD, standard deviation.